SERPINx will be present at the upcoming 13th annual BioEurope Spring partnering conference, March 25th to March 27th in Vienna, Austria.

SERPINx will be meeting with investors and service providers during the BioEurope Spring to initiate further development and seed/series A funding for their lead compound SPx-001 as a gene therapy for Heriditary Angioedema. We would be happy to meet with you in Vienna.

More info: https://ebdgroup.knect365.com/bioeurope-spring/